144 related articles for article (PubMed ID: 7460402)
21. Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale.
Laine JF; Slama M; Petitpretz P; Girard P; Motté G
Chest; 1986 Jun; 89(6):894-5. PubMed ID: 3709258
[TBL] [Abstract][Full Text] [Related]
22. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
23. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
Halpern SM; Shah PK; Lehrman S; Goldberg HS; Jasper AC; Koerner SK
Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.
Perez HD; Kramer N
Semin Arthritis Rheum; 1981 Aug; 11(1):177-81. PubMed ID: 7025213
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases.
Asherson RA; Hackett D; Gharavi AE; Harris EN; Kennedy HG; Hughes GR
J Rheumatol; 1986 Apr; 13(2):416-20. PubMed ID: 3088276
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of systemic lupus erythematosus and pulmonary hypertension with intravenous prostaglandin I2 followed by its oral analogue.
Ooiwa H; Miyazawa T; Yamanishi Y; Hiyama K; Ishioka S; Yamakido M
Intern Med; 2000 Apr; 39(4):320-3. PubMed ID: 10801148
[TBL] [Abstract][Full Text] [Related]
28. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.
Chung SM; Lee CK; Lee EY; Yoo B; Lee SD; Moon HB
Clin Rheumatol; 2006 Nov; 25(6):866-72. PubMed ID: 16496078
[TBL] [Abstract][Full Text] [Related]
29. Primary pulmonary hypertension associated with systemic lupus erythematosus.
Turner A; Samanta A; Nichol FE
Clin Rheumatol; 1991 Sep; 10(3):320-2. PubMed ID: 1790644
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus and pulmonary vascular hypertension.
Schwartzberg M; Lieberman DH; Getzoff B; Ehrlich GE
Arch Intern Med; 1984 Mar; 144(3):605-7. PubMed ID: 6703830
[TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus and pulmonary hypertension.
Scherak O; Kolarz G
Z Rheumatol; 1981; 40(3):131-4. PubMed ID: 7282111
[TBL] [Abstract][Full Text] [Related]
32. Effects of supplemental oxygen administration in an infant with pulmonary artery hypertension.
Palmisano JM; Martin JM; Krauzowicz BA; Truman KH; Meliones JN
Heart Lung; 1990 Nov; 19(6):627-30. PubMed ID: 2228653
[TBL] [Abstract][Full Text] [Related]
33. Deleterious effects of hydralazine in patients with pulmonary hypertension.
Packer M; Greenberg B; Massie B; Dash H
N Engl J Med; 1982 Jun; 306(22):1326-31. PubMed ID: 7070457
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
Priebe HJ
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension in systemic lupus erythematosus.
Schreiber BE; Connolly MJ; Coghlan JG
Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):425-34. PubMed ID: 24238697
[TBL] [Abstract][Full Text] [Related]
36. [A case of systemic lupus erythematosus with pulmonary hypertension].
Nakano K; Tanaka Y; Aso M; Saito K; Fujii K; Takazawa A; Ota T
Ryumachi; 2000 Jun; 40(3):612-9. PubMed ID: 10920686
[TBL] [Abstract][Full Text] [Related]
37. Predictive Value of Pulmonary Arterial Compliance in Systemic Lupus Erythematosus Patients With Pulmonary Arterial Hypertension.
Guo X; Lai J; Wang H; Tian Z; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
Hypertension; 2020 Oct; 76(4):1161-1168. PubMed ID: 32772648
[TBL] [Abstract][Full Text] [Related]
38. [A case of systemic lupus erythematosus complicated with pulmonary hypertension and massive pericardial effusion].
Tsuji S; Akizuki S; Matsuoka Y; Irimajiri S
Ryumachi; 1991 Apr; 31(2):194-8. PubMed ID: 1925798
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
[TBL] [Abstract][Full Text] [Related]
40. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.
Groen H; Bootsma H; Postma DS; Kallenberg CG
J Rheumatol; 1993 Jun; 20(6):1055-7. PubMed ID: 8350313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
